China Pioneer Pharma Holdings Limited

HKEX:1345.HK

2.08 (HKD) • At close September 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q22011 Q12010 Q42010 Q32010 Q22010 Q12009 Q4
Revenue 829.762736.911896.63659.41748.987685.833709.542622.495695.725620.253672.683951.6221,125.7531,028.182984.246806.029657.656803.243801.611738.787720.917551.33318.062239.681239.681239.681239.681179.458179.458179.458179.458142.662142.662142.662142.662
Cost of Revenue 477.95420.484472.524303.05355.313307.478353.252370.819320.98315.202371.962619.919731.155701.359642.139554.719447.804550.518550.917497.532497.503388.097221.4162.995162.995162.995162.995130.532130.532130.532130.532101.139101.139101.139101.139
Gross Profit 351.812316.427424.106356.36393.674378.355356.29251.676374.745305.051300.721331.703394.598326.823342.107251.31209.852252.725250.694241.255223.414163.23396.66276.68676.68676.68676.68648.92648.92648.92648.92641.52341.52341.52341.523
Gross Profit Ratio 0.4240.4290.4730.540.5260.5520.5020.4040.5390.4920.4470.3490.3510.3180.3480.3120.3190.3150.3130.3270.310.2960.3040.320.320.320.320.2730.2730.2730.2730.2910.2910.2910.291
Reseach & Development Expenses 00000000000000000000000000000000000
General & Administrative Expenses 58.14753.95942.47739.60532.10340.22434.15731.30646.25637.92840.32334.0335.11331.44441.67431.69636.80229.94333.63521.40819.96913.5968.3917.1687.1687.1687.1684.5834.5834.5834.5833.8913.8913.8913.891
Selling & Marketing Expenses 205.457217.147250217.744272.708244.495260.907182.832238.677208.126224.317175.338217.4152.872175.337102.15172.84162.53786.9165.74254.0247.7425.4423.02223.02223.02223.02217.16317.16317.16317.16315.95315.95315.95315.953
SG&A 262.828271.868292.165256.112298.421286.372316.023218.818293.11248.214272.763210.005252.513184.316217.011133.847109.64392.48120.54587.1573.98961.33633.83130.18930.18930.18930.18921.74621.74621.74621.74619.84419.84419.84419.844
Other Expenses 00000000000000000000-3.174-9.11-9.11-2.846-2.846-2.846-2.846-1.974-1.974-1.974-1.974-2.073-2.073-2.073-2.073
Operating Expenses 261.769227.56284.404212.146291.261283.331324.559194.412334.802208.537336.336205.272251.569176.812183.709140.257192.06784.721115.87694.3872.19641.26324.72127.34427.34427.34427.34419.77319.77319.77319.77317.77117.77117.77117.771
Operating Income 88.98444.559131.941100.24895.25391.98340.26732.85881.63556.83727.958121.698142.085142.507125.096117.463100.209160.245130.149154.105149.425101.89771.94654.23254.23254.23254.23231.81231.81231.81231.81224.30424.30424.30424.304
Operating Income Ratio 0.1070.060.1470.1520.1270.1340.0570.0530.1170.0920.0420.1280.1260.1390.1270.1460.1520.1990.1620.2090.2070.1850.2260.2260.2260.2260.2260.1770.1770.1770.1770.170.170.170.17
Total Other Income Expenses Net 1.05245.85312.86949.4398.1816.03-5.02227.239-36.74446.741-54.66612.12410.20214.52340.691-0.9-75.86122.20216.4493.985-1.86123.025-3.824-2.522-2.522-2.522-2.522-1.038-1.038-1.038-1.038-0.084-0.084-0.084-0.084
Income Before Tax 90.03690.412144.81149.687103.43498.01335.24560.09744.891103.578-26.708133.822152.287157.03165.787116.56324.348182.447146.598158.09147.564124.92268.12251.7151.7151.7151.7130.77330.77330.77330.77324.22124.22124.22124.221
Income Before Tax Ratio 0.1090.1230.1620.2270.1380.1430.050.0970.0650.167-0.040.1410.1350.1530.1680.1450.0370.2270.1830.2140.2050.2270.2140.2160.2160.2160.2160.1710.1710.1710.1710.170.170.170.17
Income Tax Expense 33.29918.15236.42628.12130.75729.87214.10829.74439.2195.4279.46412.87914.35414.35627.17816.54812.68321.61121.67722.0622.8913.8429.1835.2815.2815.2815.2816.526.526.526.525.4515.4515.4515.451
Net Income 68.71777.001113.078122.21873.74568.88821.68130.7675.9798.657-36.085120.682137.577141.348138.63898.80712.338161.964125.062136.656125.873112.49958.93946.42946.42946.42946.42924.25324.25324.25324.25318.76918.76918.76918.769
Net Income Ratio 0.0830.1040.1260.1850.0980.10.0310.0490.0090.159-0.0540.1270.1220.1370.1410.1230.0190.2020.1560.1850.1750.2040.1850.1940.1940.1940.1940.1350.1350.1350.1350.1320.1320.1320.132
EPS 0.0580.0650.0950.10.0610.0570.0180.0250.0050.081-0.0290.0960.110.110.110.0760.010.120.0940.10.110.110.0560.0350.0350.0350.0350.0180.0180.0180.0180.0140.0140.0140.014
EPS Diluted 0.0580.0650.0950.10.0610.0570.0180.0250.0050.081-0.0290.0960.110.110.110.0760.010.120.0940.10.110.110.0560.0350.0350.0350.0350.0180.0180.0180.0180.0140.0140.0140.014
EBITDA 98.31152.669137.688107.69101.7898.18445.30635.9186.2560.89431.913125.829147.304145.607131.508124.231110.097167.238136.067155.788150.382103.4272.56654.93654.93654.93654.93632.44432.44432.44432.44424.824.824.824.8
EBITDA Ratio 0.1180.0710.1540.1630.1360.1430.0640.0580.1240.0980.0470.1320.1310.1420.1340.1540.1670.2080.170.2110.2090.1880.2280.2290.2290.2290.2290.1810.1810.1810.1810.1740.1740.1740.174